EUVIMEDEUVIMED entdecken
Crossref

Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice

Yoshiyuki Kimura iD, Masahiko Taniguchi, Takuo Okuda

Planta Medica · 01.06.2023 · 89 (07) · 746-753

DOI: 10.1055/a-2037-2995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.06.2023. Verfasst von Yoshiyuki Kimura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, Nasahara, Takatsuki, Osaka, Japan. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Colitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study investigates the effects of acertannin on colitis induced by dextran sulfate sodium (DSS) and changes in the colonic levels of the cytokines interleukin (IL)-1β, IL-6, IL-10, IL-23, tumor necrosis factor (TNF)-α, the chemokine monocyte chemoattractant protein (MCP)-1, and vascular endothelial growth factor (VEGF). We examine the following: inflammatory colitis was induced in mice by 2% DSS drinking water given ad libitum for 7 days. Red blood cell, platelets, and leukocyte counts and hematocrit (Ht), hemoglobin (Hb), and colonic cytokine and chemokine levels were measured. The disease activity index (DAI) was lower in DSS-treated mice orally administered acertannin (30 and 100 mg/kg) than in DSS-treated mice. Acertannin (100 mg/kg) inhibited reductions in the red blood cell count and Hb and Ht levels in DSS-treated mice. Acertannin prevented DDS-induced mucosal membrane ulceration of the colon and significantly inhibited the increased colonic levels of IL-23 and TNF-α. Our findings suggest that acertannin has potential as a treatment for inflammatory bowel disease (IBD).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaColitisMiceAnimalsDextran SulfateInterleukin-23Mice, Inbred C57BLVascular Endothelial Growth Factor AColonCytokinesDisease Models, Animal

Substanzen

Tumor Necrosis Factor-alphaDextran SulfateInterleukin-23Vascular Endothelial Growth Factor ACytokines

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, Nasahara, Takatsuki, Osaka, Japan.
  • Previous affiliation: Department of Functional Biomedicine, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
  • Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, Japan.

ORCID-Profile: Yoshiyuki Kimura

Förderung

  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Kimura, Y., Taniguchi, M., & Okuda, T. (2023). Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice. Planta Medica, 89(07), 746-753. https://doi.org/10.1055/a-2037-2995

Vancouver

Kimura Y, Taniguchi M, Okuda T. Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice. Planta Medica. 2023;89(07):746-753. doi:10.1055/a-2037-2995

BibTeX
@article{Kimura2023,
  author = {Kimura, Yoshiyuki and Taniguchi, Masahiko and Okuda, Takuo},
  title = {Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice},
  journal = {Planta Medica},
  year = {2023},
  volume = {89},
  number = {07},
  pages = {746--753},
  doi = {10.1055/a-2037-2995}
}
Kostenlos starten →